Next-Gen Sensor & Algorithm Development
Diabetes Management
DevelopmentActive
Key Facts
About Medtrum France
Medtrum France, founded in 2014, is a private medical device company specializing in the development of automated insulin delivery systems for diabetes care. The company's technology platform integrates its proprietary insulin patch pumps with continuous glucose monitoring to create a hybrid closed-loop system aimed at improving glycemic control. Operating from Vienna, Austria, it targets the growing global market for diabetes management technologies, competing against larger, established players by focusing on user-friendly, connected solutions. As a commercial-stage company, it generates revenue through the sale of its medical devices and associated disposables.
View full company profileOther Diabetes Management Drugs
| Drug | Company | Phase |
|---|---|---|
| CGM Integrations (Dexcom, Abbott) | Tandem Diabetes | Partnership |
| ALRT Diabetes Solution | ALR Technologies | Approved/Commercial |
| Continuous Glucose Monitor | Allez Health | Approved |
| Regulatory Expansion (e.g., FDA Submission) | Medtrum France | Regulatory |
| CONTOUR BGM Portfolio Development | Ascensia Diabetes Care | Commercial |
| Next-Gen Hardware/Software | Insulet | R&D |
| CGM Ecosystem Integration | Insulet | Development/Regulatory |